Covid Nasal Vaccine
- All
- News
- Videos
-
Covid Nasal Vaccine A "Mighty Display Of India's Research: Health Minister
Mansukh Manadaviya said that the world's first intranasal vaccine for Covid-19 iNCOVACC launched is a testimony to the innovative zeal of our scientists and a display of India's research and innovation prowess under the leadership of PM Modi.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
World's 1st Covid Nasal Vaccine, Made In India, To Be Out On Republic Day
Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26.
-
Can't Take Nasal Vaccine After Booster: Covid Task Force Chief To NDTV
India's nasal vaccine cannot be administered to those who have taken a precaution or booster dose, the head of the country's vaccine task force told NDTV today in an exclusive interview.
-
Covid Nasal Vaccine: How To Book It, How Much It Costs
Bharat Biotech's nasal vaccine will cost Rs 800 plus taxes at private hospitals and slots can now be booked on the CoWin's portal, the pharmaceutical major has announced.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
-
Nasal Vaccine From Today, Hospital Drills - Preps In Top Gear: 10 Facts
Mock drills will be conducted at hospitals across the country from Tuesday onwards in view of a spike in Covid cases in some countries, the union health ministry said today, adding that it is preparing fresh guidelines for Christmas and New Year.
-
Bharat Biotech Asks Centre To List Its Nasal Covid Vaccine On CoWIN Portal: Report
Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate.
-
Bharat Biotech To Launch 1st Nasal Covid Vaccine, No Efficacy Data Released
Bharat Biotech's needle-free intranasal Covid vaccine has been cleared for restricted use in emergency situations for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine in the world.
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
New Intranasal Anti-Viral Treatment May Block Covid Transmission: Report
Researchers have developed an intranasal anti-viral treatment for COVID-19 that decreases the amount of SARS-CoV-2 shed from infected animals and limits transmission of the virus.
-
Nasal Vaccines Could Be Beneficial In Controlling Covid: WHO
Nasal Covid-19 vaccines could help to bring the Covid-19 pandemic under control, the World Health Organization said Wednesday after homegrown products were approved in India and China.
-
Bharat Biotech's Nasal Vaccine Against Covid-19 Cleared For Use
Union Health Minister Dr Mansukh Mandaviya tweets that it's "a big boost to India's Fight against Covid-19"
-
Covid Nasal Vaccine's Phase 3 Trials Completed, Says Bharat Biotech Chief
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India next month.
-
Covid Nasal Vaccine A "Mighty Display Of India's Research: Health Minister
Mansukh Manadaviya said that the world's first intranasal vaccine for Covid-19 iNCOVACC launched is a testimony to the innovative zeal of our scientists and a display of India's research and innovation prowess under the leadership of PM Modi.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
World's 1st Covid Nasal Vaccine, Made In India, To Be Out On Republic Day
Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26.
-
Can't Take Nasal Vaccine After Booster: Covid Task Force Chief To NDTV
India's nasal vaccine cannot be administered to those who have taken a precaution or booster dose, the head of the country's vaccine task force told NDTV today in an exclusive interview.
-
Covid Nasal Vaccine: How To Book It, How Much It Costs
Bharat Biotech's nasal vaccine will cost Rs 800 plus taxes at private hospitals and slots can now be booked on the CoWin's portal, the pharmaceutical major has announced.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
-
Nasal Vaccine From Today, Hospital Drills - Preps In Top Gear: 10 Facts
Mock drills will be conducted at hospitals across the country from Tuesday onwards in view of a spike in Covid cases in some countries, the union health ministry said today, adding that it is preparing fresh guidelines for Christmas and New Year.
-
Bharat Biotech Asks Centre To List Its Nasal Covid Vaccine On CoWIN Portal: Report
Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate.
-
Bharat Biotech To Launch 1st Nasal Covid Vaccine, No Efficacy Data Released
Bharat Biotech's needle-free intranasal Covid vaccine has been cleared for restricted use in emergency situations for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine in the world.
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
New Intranasal Anti-Viral Treatment May Block Covid Transmission: Report
Researchers have developed an intranasal anti-viral treatment for COVID-19 that decreases the amount of SARS-CoV-2 shed from infected animals and limits transmission of the virus.
-
Nasal Vaccines Could Be Beneficial In Controlling Covid: WHO
Nasal Covid-19 vaccines could help to bring the Covid-19 pandemic under control, the World Health Organization said Wednesday after homegrown products were approved in India and China.
-
Bharat Biotech's Nasal Vaccine Against Covid-19 Cleared For Use
Union Health Minister Dr Mansukh Mandaviya tweets that it's "a big boost to India's Fight against Covid-19"
-
Covid Nasal Vaccine's Phase 3 Trials Completed, Says Bharat Biotech Chief
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India next month.